ENT Devices Industry Is Projected To Grow At A CAGR Of 6.1% Over The Coming 10 Years

Global sales of ENT Devices market in 2021 was held at US$ 21.9 Bn. With 6.1%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth. The absolute dollar opportunity for ENT Devices market will be witnessing US$ 18.5 Bn absolute $ opportunity.

This report's condition demand analysis is guiding businesses in order to save labour costs and time. This report also discusses the competitive landscape, which includes information on the major market players as well as their market share. The data presented in this study is derived from reliable websites, organisation websites and reports, global forums, and industry experts. Primary and secondary research methods are used to ensure that all necessary data is included. Readers will benefit from the research in both qualitative and quantitative aspects.

Download Sample Copy of This Report :-https://www.factmr.com/connectus/sample?flag=S&rep_id=7199

Market Segments Covered in ENT Devices Industry Analysis

• By Product Type :

o Diagnostic ENT Devices
 Rigid Endoscopes
 Flexible Endoscopes
 Robot Assisted Endoscope
 Hearing Screening Device
o Surgical ENT Devices
 Radiofrequency Handpieces
 Otological Drill Burrs
 ENT Hand Instruments
 Sinus Dilation Devices
 Nasal Packing Devices
o Hearing Aids
o Hearing Implants
o Nasal Splints

• By Region :

o North America
o Latin America
o Europe
o APAC
o MEA

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=7199

What will be the Growth Prospects of ENT Devices ?

The growth prospects of ENT devices are very promising. The global ENT devices market is expected to grow at a CAGR of 6.2% from 2020 to 2027, reaching a value of USD 8.3 billion by 2027. This growth is attributed to the increasing prevalence of ear, nose, and throat diseases, technological advancements in ENT devices, and the rising demand for minimally invasive surgical procedures. Additionally, the increasing number of ENT surgeries and the growing geriatric population are expected to drive the growth of the ENT devices market.

Competitive Analysis

The ENT devices market is significantly competitive where a handful of players dominate the market. The key market players of the studied market comprise Medtronic, Acclarent, Demant A/S, Sonova, Ambu A/S., Pentax Medical, Karl Storz, Olympus Corporation, Richard Wolf Gmbh, Widex, Cochlear Ltd., Sivantos, Inc., Starkey Hearing Technologies, Gn Resound A/S, Rion Co., Ltd., Welch Allyn, Atos Medical AB, and Zsquare.

The recent development in ent devices markets are:
• In March 2022, Zsquare, a developer of high-performance, single-use endoscopes, has received US$ 15 Mn worth of equity financing from a joint venture investment group as the part of its soft-launch of its disruptor next-generation ENT endoscope. The soft-launch will take place following federal FDA approval anticipated in the third quarter of 2022.
• In Feb 2022, Medtronic plc announced the introduction of NuVentTM balloon, which the FDA approved for lasting treatment of chronic, obstructive Eustachian Tube Dysfunction. The NuVent balloon allows for speedy outpatient or in-office treatment.
• In September 2021, Acclarent announced the launch of its ENT technology, which uses AI to simplify surgical planning provide real-time feedback during ENT navigation procedures. Initially the system will be limited to the U.S. The new software package contains TruSeg and TruPath for use with the TruDi Navigation System and leverages a machine learning algorithm to provide reliable and efficient image guided preoperative planning and navigation for ENT procedures, such as endoscopic sinus surgery.
• In August 2021, Medtronic announced that it has reached an agreement to acquire Covidien's ENT devices business for $1.1 B in cash. The move is expected to help Medtronic expand its presence in the growing global market for ENT devices. The acquisition is also expected to provide Medtronic with a stronger product portfolio and increase its market share in key geographies.

Get Full Access of This Premium Report :- https://www.factmr.com/checkout/7199

How FactMR will assure you about meeting your expectations from our end?

The customization request from clients is treated with at most priority at FactMR and passed with higher importance to our team of analysts. Our team will generate client-centric customized research. Our team goes the extra mile and connects with you over a call or mail if required.

Read More Trending Reports of Fact.MR-
https://www.globenewswire.com/en/news-release/2022/09/22/2521139/0/en/Global-Softgels-Dietary-Supplements-Market-Value-to-reach-US-15-8-Billion-by-2032-General-Well-Being-remains-primary-Application-Area-Fact-MR-Forecast.html

US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Us:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.